11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
Bricker & Eckler's construction attorneys are proud to present "Top Gun," our premier Midwest constr...
Read More >
Construction unions, traditionally male-dominated, are leveraging the growing presence of women in t...
Read More >
As 2019 comes to a close, legislative and administrative actions in New York require consideration b...
Read More >
As you may know, the Department of Labor has included the proposal of a new fiduciary rule on its Re...
Read More >
On January 13, 2020, the U.S. Department of the Treasury, which chairs the Committee on Foreign Inve...
Read More >
For M&A transactions in Germany and beyond, Foreign Investment Control screenings have become an ind...
Read More >